Comparison 1. CS‐NANP vaccine versus control.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 New malaria infection | 3 | 307 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.05 [0.82, 1.35] |
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 New malaria infection | 3 | 307 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.05 [0.82, 1.35] |